Wafra Inc’s Bristol-Myers Squibb BMY Stock Holding History

Wafra Inc’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-70,401	Closed	-$4.31M	–	82
2017 Q4	$4.31M	Buy	70,401 +4,563	+7%	+$285K	0.2%	62
2017 Q3	$4.2M	Buy	+65,838	New	+$3.84M	0.2%	60
2016 Q3	–	Sell	-344,852	Closed	-$25.4M	–	78
2016 Q2	$25.4M	Buy	344,852 +53,230	+18%	+$3.76M	3.09%	5
2016 Q1	$18.6M	Buy	291,622 +268,519	+1,162%	+$16.9M	2.12%	20
2015 Q4	$1.59M	Buy	23,103 +2,103	+10%	+$139K	0.18%	59
2015 Q3	$1.24M	Hold	21,000	–	–	0.15%	55
2015 Q2	$1.4M	Hold	21,000	–	–	0.15%	58
2015 Q1	$1.35M	Hold	21,000	–	–	0.14%	60
2014 Q4	$1.24M	Hold	21,000	–	–	0.13%	57
2014 Q3	$1.07M	Hold	21,000	–	–	0.12%	53
2014 Q2	$1.02M	Hold	21,000	–	–	0.13%	64
2014 Q1	$1.09M	Hold	21,000	–	–	0.13%	63
2013 Q4	$1.12M	Hold	21,000	–	–	0.14%	69
2013 Q3	$972K	Hold	21,000	–	–	0.14%	63
2013 Q2	$938K	Buy	+21,000	New	+$912K	0.15%	60

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wafra Inc's BMY Position: Q1 2018 in Review

Wafra Inc sold out of Bristol-Myers Squibb (BMY) in Q1 2018, closing a stake of 70,401 shares — an estimated $4.31M sold.

Wafra Inc first reported a position in BMY in Q2 2013 and held it in 15 quarters. The position peaked at $25.4M in Q2 2016. 1,747 funds tracked by Wall St. Rank hold BMY as of Q1 2018.

Wafra Inc reported no remaining Bristol-Myers Squibb position as of Q1 2018 after selling out during the quarter.
Wafra Inc sold 70,401 Bristol-Myers Squibb shares in Q1 2018, an estimated $4.31M.
Wafra Inc first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 15 quarters.
Wafra Inc's Bristol-Myers Squibb position peaked at $25.4M in Q2 2016.
1,747 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2018.

Based on Wafra Inc's 13F filing for Q1 2018, filed 15 May 2018.